GleamWall
中文EN

GKOS GLAUKOS Corp

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 1192448 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY46.9%
TTM net income YoY-93.8%
TTM EPS YoY-91.6%
Revenue 3-yr CAGR31.5%
Net income 3-yr CAGR—

Margins

Gross margin64.8%
Operating margin-25.5%
Net margin-24.6%
FCF margin5.2%
EBITDA margin-19.5%

Returns

ROE-22.8%
ROA-17.2%
ROIC (approx.)-22.8%
Asset turnover0.70x

Leverage & solvency

Liabilities / assets26.8%
Debt / equity0.00x
Current ratio4.57x
Interest coverage-36.57x

Cash quality & payout

Operating cash flow / net income-0.28x
Accruals ratio-22.0%
Payout ratio—
Capex / revenue1.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$507.44M$383.48M$314.71M$282.86M$294.01M
Cost of revenue$111.81M$94.03M$75.58M$68.98M$66.63M
Gross profit$282.76M$289.45M$239.14M$213.88M$227.38M
R&D expense$150.61M$136.43M$138.77M$123.27M$101.00M
SG&A expense$331.75M$261.17M$224.07M$192.93M$179.26M
Operating income-$199.60M-$122.37M-$128.70M-$82.31M-$32.87M
Interest expense$4.63M$10.04M$13.63M$13.72M$13.37M
Pretax income-$193.04M-$145.60M-$133.73M-$98.43M-$49.27M
Income tax-$5.35M$771,000$934,000$766,000$326,000
Net income-$187.69M-$146.37M-$134.66M-$99.19M-$49.59M
EBITDA-$161.51M-$86.72M-$95.05M-$50.74M-$3.21M
EPS (basic)-3.28-2.77-2.78-2.09-1.07
EPS (diluted)-3.28-2.77-2.78-2.09-1.07
Weighted avg. shares (diluted)57.19M52.76M48.43M47.44M46.42M
Balance sheet
Cash & equivalents$90.81M$174.36M$93.47M$126.60M$110.12M
Receivables$108.61M$60.74M$39.85M$36.07M$33.44M
Inventory$63.56M$57.68M$41.99M$37.84M$23.01M
Current assets$474.98M$449.79M$395.46M$443.86M$486.13M
PP&E, net$113.25M$97.87M$103.21M$94.40M$68.97M
Goodwill$66.71M$66.13M$66.13M$66.13M$66.13M
Intangibles$141.92M$263.44M$282.96M$307.87M$332.78M
Total assets$893.49M$974.76M$940.41M$1.00B$1.05B
Current liabilities$101.28M$75.12M$74.01M$72.36M$63.36M
Total liabilities$237.33M$207.82M$478.65M$472.38M$462.55M
Shareholders' equity$656.15M$766.93M$461.77M$530.00M$587.15M
Shares outstanding57.51M56.44M49.12M47.75M46.97M
Cash flow statement
Operating cash flow-$14.79M-$61.32M-$57.76M-$33.08M$24.71M
Capital expenditure$7.67M$6.30M$20.25M$30.27M$47.78M
Free cash flow-$22.45M-$67.62M-$78.01M-$63.35M-$23.08M
Investing cash flow-$77.61M$47.83M$14.10M$44.78M-$58.23M
Financing cash flow$11.89M$91.54M$15.04M$6.25M$39.26M
Depreciation & amortization$38.09M$35.65M$33.65M$31.58M$29.66M
Stock-based compensation$63.22M$50.21M$43.53M$38.56M$30.15M

Free plan shows the latest 5 periods; Pro shows all 13 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-19 06:28.